The Impact of Precision Medicine on Personalized Cancer Treatment Outcomes

Abstract

By customizing treatments according to patients' unique genetic, molecular, and environmental characteristics, precision medicine is changing the face of cancer treatment. By taking this tack, we can craft treatment plans that are unique to each patient, which improves results while decreasing side effects. Here we take a look at how molecular profiling, targeted therapy development, and the discovery of actionable mutations have all contributed to precision medicine's influence on cancer treatment. Personalized treatment strategies have improved response rates and survival outcomes for many malignancies, including breast, lung, and colorectal cancers, thanks to the integration of next-generation sequencing (NGS) and biomarker identification. Nevertheless, there are still major hurdles to overcome, including tumor heterogeneity, medication resistance, and the availability of precision treatments. This paper reviews the current state of precision medicine in oncology, identifies its strengths and weaknesses, and then moves on to talk about how to improve cancer treatment by bringing it into more clinical settings.